Gene: NR1H2
Official Full Name: nuclear receptor subfamily 1 group H member 2provided by HGNC
Gene Summary: The liver X receptors, LXRA (NR1H3; MIM 602423) and LXRB, form a subfamily of the nuclear receptor superfamily and are key regulators of macrophage function, controlling transcriptional programs involved in lipid homeostasis and inflammation. The inducible LXRA is highly expressed in liver, adrenal gland, intestine, adipose tissue, macrophages, lung, and kidney, whereas LXRB is ubiquitously expressed. Ligand-activated LXRs form obligate heterodimers with retinoid X receptors (RXRs; see MIM 180245) and regulate expression of target genes containing LXR response elements (summary by Korf et al., 2009 [PubMed 19436111]).[supplied by OMIM, Jan 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00071 | NR1H2 Knockout cell line (Vips) | Human | NR1H2 | Negative | Online Inquiry | |
KO00944 | NR1H2 Knockout cell line(293T) | Human | NR1H2 | 1:3~1:6 | Negative | Online Inquiry |
KO15643 | NR1H2 Knockout cell line (HeLa) | Human | NR1H2 | 1:3~1:6 | Negative | Online Inquiry |
KO15644 | NR1H2 Knockout cell line (HCT 116) | Human | NR1H2 | 1:2~1:4 | Negative | Online Inquiry |
KO15645 | NR1H2 Knockout cell line (HEK293) | Human | NR1H2 | 1:3~1:6 | Negative | Online Inquiry |
KO15646 | NR1H2 Knockout cell line (A549) | Human | NR1H2 | 1:3~1:4 | Negative | Online Inquiry |
NR1H2 Gene Knockout Cell Lines are specialized genetically engineered cell lines wherein the NR1H2 gene, also known as Liver X Receptor beta (LXRβ), has been effectively disrupted. These cell lines are used as a critical tool for understanding the biological roles of NR1H2 in lipid metabolism, inflammation, and cholesterol homeostasis. By knocking out this gene, researchers can explore the resultant phenotypic changes in cellular processes and signaling pathways related to these essential metabolic functions.
The primary function of NR1H2 involves the regulation of genes associated with lipid uptake, regulation, and efflux, thereby playing a pivotal role in cholesterol metabolism. The knockout mechanism leads to the abrogation of LXRβ functionality, thus providing insights into the compensatory pathways that may activate in response to altered lipid profiles. Researchers can utilize these cell lines to dissect the molecular underpinnings of metabolic disorders, assess new therapeutic targets, and evaluate the efficacy of pharmacological agents that interact with lipid metabolism pathways.
In a research context, the NR1H2 Gene Knockout Cell Lines are instrumental for both in vitro and in vivo studies aimed at clarifying the contribution of LXRβ to disease states, such as atherosclerosis, obesity, and diabetes. In clinical applications, these cell lines enable the development of novel intervention strategies by providing a reliable platform for drug discovery and testing.
A distinct advantage of these knockout cell lines is their specificity and robustness compared to traditional models that may not adequately recapitulate the loss of gene function. This specificity allows for clearer interpretation of experimental results, minimizing off-target effects that can confound data interpretation. Furthermore, these cell lines are readily available, easily maintained, and compatible with a variety of assays, making them a versatile addition to any laboratory focused on metabolic research.
Researchers and clinicians alike will find immense value in utilizing NR1H2 Gene Knockout Cell Lines due to their capacity to advance our understanding of metabolic regulation and their potential to inform therapeutic development. Our company specializes in providing high-quality biological products, ensuring that researchers have access to the tools necessary for groundbreaking discoveries in cellular and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.